Biohaven [BHVN] vs Liquidia [LQDA] Detailed Stock Comparison
Biohaven
NYSE
Loading...
Liquidia
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Biohaven wins in 4 metrics, Liquidia wins in 11 metrics, with 0 ties. Liquidia appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Biohaven | Liquidia | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.70 | -13.51 | Liquidia |
| Price-to-Book Ratio | 12.43 | 126.72 | Biohaven |
| Debt-to-Equity Ratio | 25.63 | 1,319.26 | Biohaven |
| PEG Ratio | 0.04 | -0.42 | Liquidia |
| EV/EBITDA | -1.40 | -14.31 | Liquidia |
| Profit Margin (TTM) | 0.00% | 58.00% | Liquidia |
| Operating Margin (TTM) | 0.00% | -424.41% | Biohaven |
| Return on Equity | -295.94% | -389.13% | Biohaven |
| Return on Assets (TTM) | -103.41% | -39.74% | Liquidia |
| Free Cash Flow (TTM) | $-586.50M | $-101.87M | Liquidia |
| 1-Year Return | -66.81% | 101.17% | Liquidia |
| Price-to-Sales Ratio (TTM) | N/A | 99.94 | N/A |
| Enterprise Value | $1.30B | $1.96B | Liquidia |
| EV/Revenue Ratio | N/A | 101.34 | N/A |
| Gross Profit Margin (TTM) | N/A | 83.06% | N/A |
| Revenue per Share (TTM) | $0 | $0 | Liquidia |
| Earnings per Share (Diluted) | $-7.46 | $-1.82 | Liquidia |
| Beta (Stock Volatility) | 3.45 | 0.16 | Liquidia |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Biohaven vs Liquidia Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biohaven | 1.93% | 5.40% | -2.47% | 8.07% | -23.07% | -57.59% |
| Liquidia | 2.42% | 2.89% | -23.24% | 84.00% | 58.74% | 85.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biohaven | -66.81% | 22.65% | 116.58% | -11.73% | -11.73% | -11.73% |
| Liquidia | 101.17% | 312.32% | 316.91% | 104.09% | 104.09% | 104.09% |
News Based Sentiment: Biohaven vs Liquidia
Biohaven
News based Sentiment: POSITIVE
The month of October 2025 brought continued positive signals for Biohaven Ltd. (BHVN), with analysts reaffirming a "Strong Buy" rating and a substantial price target upside. While the share price increase was modest, the overall sentiment suggests a favorable investment outlook.
Liquidia
News based Sentiment: MIXED
Liquidia is facing both opportunities and challenges this month. The potential expansion into the IPF market is a positive catalyst, but the ongoing patent litigation with United Therapeutics and bearish options trading activity introduce significant uncertainty. This creates a mixed investment narrative.
Performance & Financial Health Analysis: Biohaven vs Liquidia
| Metric | BHVN | LQDA |
|---|---|---|
| Market Information | ||
| Market Cap | $1.69B | $1.93B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,276,949 | 3,320,420 |
| 90 Day Avg. Volume | 2,397,840 | 2,676,227 |
| Last Close | $15.81 | $22.43 |
| 52 Week Range | $12.79 - $55.70 | $9.71 - $29.94 |
| % from 52W High | -71.62% | -25.08% |
| All-Time High | $67.86 (Jun 03, 2019) | $38.46 (Oct 08, 2018) |
| % from All-Time High | -76.70% | -41.68% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 1.42% |
| Quarterly Earnings Growth | N/A | 1.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.58% |
| Operating Margin (TTM) | 0.00% | -4.24% |
| Return on Equity (TTM) | -2.96% | -3.89% |
| Debt to Equity (MRQ) | 25.63 | 1,319.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.27 | $0.18 |
| Cash per Share (MRQ) | $3.83 | $2.01 |
| Operating Cash Flow (TTM) | $-645,078,016 | $-116,055,000 |
| Levered Free Cash Flow (TTM) | $-508,353,632 | $-71,345,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Biohaven vs Liquidia
| Metric | BHVN | LQDA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.70 | -13.51 |
| Forward P/E | -2.50 | -14.38 |
| PEG Ratio | 0.04 | -0.42 |
| Price to Sales (TTM) | N/A | 99.94 |
| Price to Book (MRQ) | 12.43 | 126.72 |
| Market Capitalization | ||
| Market Capitalization | $1.69B | $1.93B |
| Enterprise Value | $1.30B | $1.96B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | 101.34 |
| Enterprise to EBITDA | -1.40 | -14.31 |
| Risk & Other Metrics | ||
| Beta | 3.45 | 0.16 |
| Book Value per Share (MRQ) | $1.27 | $0.18 |
Financial Statements Comparison: Biohaven vs Liquidia
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BHVN | LQDA |
|---|---|---|
| Revenue/Sales | $0 | $3.12M |
| Cost of Goods Sold | N/A | $1.52M |
| Gross Profit | N/A | $1.60M |
| Research & Development | $187.58M | $6.97M |
| Operating Income (EBIT) | $-221.56M | $-35.43M |
| EBITDA | $-219.32M | $-33.25M |
| Pre-Tax Income | $-221.07M | $-38.37M |
| Income Tax | $609,000 | N/A |
| Net Income (Profit) | $-221.68M | $-38.37M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BHVN | LQDA |
|---|---|---|
| Cash & Equivalents | $98.42M | $169.76M |
| Total Current Assets | $382.76M | $177.21M |
| Total Current Liabilities | $164.03M | $60.52M |
| Long-Term Debt | $30.80M | $109.66M |
| Total Shareholders Equity | $259.50M | $49.71M |
| Retained Earnings | $-1.57B | $-595.76M |
| Property, Plant & Equipment | $36.78M | $11.49M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BHVN | LQDA |
|---|---|---|
| Operating Cash Flow | $-164.28M | $-26.68M |
| Capital Expenditures | $-461,000 | $-330,000 |
| Free Cash Flow | $-165.59M | $-31.01M |
| Debt Repayment | N/A | $-2.19M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BHVN | LQDA |
|---|---|---|
| Shares Short | 13.19M | 18.47M |
| Short Ratio | 6.20 | 7.92 |
| Short % of Float | 0.14% | 0.27% |
| Average Daily Volume (10 Day) | 2,276,949 | 3,320,420 |
| Average Daily Volume (90 Day) | 2,397,840 | 2,676,227 |
| Shares Outstanding | 101.22M | 84.68M |
| Float Shares | 88.38M | 60.86M |
| % Held by Insiders | 0.12% | 0.13% |
| % Held by Institutions | 0.83% | 0.71% |
Dividend Analysis & Yield Comparison: Biohaven vs Liquidia
| Metric | BHVN | LQDA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |